Xu Y - Search Results

1

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study.

Luo MN, Pan Q, Ye T, Li S, Yang L, Liu HF, Xu Y. Luo MN, et al. Among authors: xu y. Front Pharmacol. 2023 Mar 14;14:1093442. doi: 10.3389/fphar.2023.1093442. eCollection 2023. Front Pharmacol. 2023. PMID: 36998610 Free PMC article.

2

[Evaluation of the relationship between IL-18 levels in urine and parameters of renal pathological changes in patients with lupus nephritis].

Liu HF, Xu YZ, Yao CW, Chen T, Hong T, Liang D, Chen XW. Liu HF, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Nov;22(6):777-8, 780. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006. PMID: 17077020 Chinese.

3

[Effect of bone morphogenetic protein-7 on aristolochic acid induced renal tubular epithelial cells transdifferentiation].

Xu YZ, Huang H, Liu HF. Xu YZ, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Feb;30(2):157-60. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010. PMID: 20462043 Chinese.

4

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.

Luo MN, Yao CW, Xu BH, Xu YZ, Liu WJ, Feng YM, Tao JL, Liu HF. Luo MN, et al. Exp Ther Med. 2014 Mar;7(3):553-559. doi: 10.3892/etm.2013.1467. Epub 2013 Dec 31. Exp Ther Med. 2014. PMID: 24520244 Free PMC article.

5

Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.

Yang C, Guo Y, Huang TS, Zhao J, Huang XJ, Tang HX, An N, Pan Q, Xu YZ, Liu HF. Yang C, et al. Among authors: xu yz. Biomed Pharmacother. 2018 Nov;107:1354-1362. doi: 10.1016/j.biopha.2018.08.126. Epub 2018 Aug 30. Biomed Pharmacother. 2018. PMID: 30257350

6

Current mechanistic insights into the role of infection in systemic lupus erythematosus.

Pan Q, Liu Z, Liao S, Ye L, Lu X, Chen X, Li Z, Li X, Xu YZ, Liu H. Pan Q, et al. Biomed Pharmacother. 2019 Sep;117:109122. doi: 10.1016/j.biopha.2019.109122. Epub 2019 Jun 18. Biomed Pharmacother. 2019. PMID: 31226637 Free article. Review.

7

Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development.

Pan Q, Chen X, Liao S, Chen X, Zhao C, Xu YZ, Liu HF. Pan Q, et al. PeerJ. 2019 Jun 25;7:e7179. doi: 10.7717/peerj.7179. eCollection 2019. PeerJ. 2019. PMID: 31275761 Free PMC article.

8

Cross-regulation between exosomal and autophagic pathways: promising therapy targets in disease.

Lin J, Lu X, Liao S, Chen X, Wang S, Zhao C, Li X, Xu YZ, Liu HF, Pan Q. Lin J, et al. Discov Med. 2019 May;27(149):201-210. Discov Med. 2019. PMID: 31361983 Free article. Review.

9

Increased number and activation of peripheral basophils in adult-onset minimal change disease.

Han H, Xu YZ, Liao S, Xiao H, Chen X, Lu X, Wang S, Yang C, Liu HF, Pan Q. Han H, et al. J Cell Mol Med. 2020 Jul;24(14):7841-7849. doi: 10.1111/jcmm.15417. Epub 2020 Jun 8. J Cell Mol Med. 2020. PMID: 32510738 Free PMC article.

10

IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy.

Luo MN, Pan Q, Huang ZQ, Li SM, Xu YZ, Liu HF. Luo MN, et al. Discov Med. 2020 Jul-Aug;30(159):19-25. Discov Med. 2020. PMID: 33357359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,307 results

Search Page

Filters